Key result
Pandemic health screening participation dropped to ~69%, yet new chronic disease diagnoses rose substantially.
Why the study?
How did changes in health screening rates during the COVID-19 pandemic influence chronic disease detection in South Korea?
Observational
Yes
How did changes in health screening rates during the COVID-19 pandemic influence chronic disease detection in South Korea?
Answers are grounded in this paper and cite their sources.
The decline in preventive health screening during the COVID-19 pandemic did not reduce chronic disease detection in South Korea, suggesting alternative diagnostic pathways maintained essential services.
Background: The COVID-19 pandemic disrupted preventive healthcare services worldwide, raising concerns about missed diagnoses of chronic diseases. South Korea's national health screening program experienced a substantial decline in participation during 2020. This study investigated how changes in screening rates influenced chronic disease detection and what these shifts reveal about the resilience of the national health system. Methods: Using the Korea Disease Control and Prevention Agency-National Health Insurance Service (K-COV-N) database, we analyzed trends in national health screening participation (2010-2020) and new diagnoses of hypertension, diabetes mellitus, and dyslipidemia before (2019) and during (2020) the COVID-19 pandemic. Analyses were stratified by sex and 10-year age groups to partially control for confounding factors. Relative risks (RRs) and 95% confidence intervals (CIs) for newly diagnosed chronic diseases were calculated for individuals who underwent health checkups and those who did not. Results: Health screening participation dropped from 75.4% in 2019 to 68.7% in 2020. Despite this decrease, new diagnoses of chronic diseases increased by approximately 550,000 cases in 2020 compared with 2019. Hypertension, diabetes, and dyslipidemia all showed higher relative risks among individuals who underwent screenings than among those who did not. Cardiovascular and cerebrovascular diseases declined, while heart failure increased slightly. Conclusion: The decline in preventive health screening did not correspond to a decline in chronic disease detection, suggesting a behavioral and systemic shift toward alternative diagnostic pathways. These findings underscore a resilient yet uneven health system, revealing both adaptive strengths and structural vulnerabilities that maintain continuity of essential services during public health crises.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) conducted an observational in Chronic diseases (hypertension, diabetes mellitus, dyslipidemia). COVID-19 pandemic (2020) vs. Pre-pandemic period (2019) was evaluated on Health screening participation. During the COVID-19 pandemic in 2020, health screening participation dropped to 68.7% from 75.4% in 2019, yet new diagnoses of chronic diseases increased by approximately 550,000 cases.
Synapse has enriched 10 related papers. Consider them for comparative context: